The class I A phosphoinositide 3-kinases (PI3Ks) consist of a 110-kDa catalytic domain and a regulatory subunit encoded by the p85␣, p85, or p55␥ genes. We have determined the effects of disrupting the p85␣ gene on the responses of mast cells stimulated by the cross-linking of Kit and Fc⑀RI, receptors that reflect innate and adaptive responses, respectively. The absence of p85␣ gene products partially inhibited Kit ligand/stem cell factor-induced secretory granule exocytosis, proliferation, and phosphorylation of the serine/threonine kinase Akt. In contrast, p85␣ gene products were not required for Fc⑀RI-initiated exocytosis and phosphorylation of Akt. LY294002, which inhibits all classes of PI3Ks, strongly suppressed Kit-and Fc⑀RI-induced responses in p85␣ ؊/؊ mast cells, revealing the contribution of another PI3K family member(s). In contrast to B lymphocytes, mast cell proliferation was not dependent on Bruton's tyrosine kinase, a downstream effector of PI3K, revealing a distinct pathway of PI3K-dependent proliferation in mast cells. Our findings represent the first example of receptor-specific usage of different PI3K family members in a single cell type. In addition, because Kit-but not Fc⑀RI-initiated signaling is associated with mast cell proliferation, the results provide evidence that distinct biologic functions signaled by these two receptors may reflect differential usage of PI3Ks.Mast cells (MCs) 1 are functionally dynamic effector cells of innate and adaptive immunity (1). Two MC surface receptors, namely, the Kit receptor (the product of the c-kit proto-oncogene) and the high affinity receptor for IgE (Fc⑀RI), provide activation via innate and adaptive immune mechanisms, respectively (2-4). Kit is a receptor tyrosine kinase belonging to the colony-stimulating factor-1/platelet-derived growth factor receptor subfamily (3). Kit is encoded by the murine White Spotting (W) locus (5, 6) and controls various cellular events during development and in adult life. Mutations at the W locus result in defects in gametogenesis, melanogenesis, and hematopoiesis (7,8). The hematopoietic defects include macrocytic anemia (8) and the virtual absence of tissue mast cells (9). Kit is expressed on both mature MCs and their earliest progenitors (10) as well as on cells of erythroid and melanocytic lineages and on germ cells (11). Kit ligand (KL; also known as stem cell factor), is expressed in membrane-associated and soluble forms (12) by mast cells (13), fibroblasts (11), endothelial cells (14), stromal cells (15), keratinocytes (16), neuroblastoma cells (17), and tumor cell lines (18). Although KL represents a major growth and differentiation factor for both murine and human MCs (19,20), it also promotes Kit-dependent MC mediator release (21-23), as well as enhances the release of MC mediators via IgE-dependent mechanisms (22,24). Fc⑀RI belongs to the antigen receptor superfamily (4). Rodent Fc⑀RI is a tetrameric receptor consisting of an ␣ chain,  chain, and a dimer of disulfide-linked ␥ chains, whereas human Fc⑀...